Correlation Between Century Therapeutics and Neurosense Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and Neurosense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and Neurosense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and Neurosense Therapeutics, you can compare the effects of market volatilities on Century Therapeutics and Neurosense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of Neurosense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and Neurosense Therapeutics.

Diversification Opportunities for Century Therapeutics and Neurosense Therapeutics

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Century and Neurosense is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and Neurosense Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurosense Therapeutics and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with Neurosense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurosense Therapeutics has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and Neurosense Therapeutics go up and down completely randomly.

Pair Corralation between Century Therapeutics and Neurosense Therapeutics

Given the investment horizon of 90 days Century Therapeutics is expected to generate 1.78 times more return on investment than Neurosense Therapeutics. However, Century Therapeutics is 1.78 times more volatile than Neurosense Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Neurosense Therapeutics is currently generating about -0.43 per unit of risk. If you would invest  136.00  in Century Therapeutics on August 30, 2024 and sell it today you would earn a total of  27.00  from holding Century Therapeutics or generate 19.85% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Century Therapeutics  vs.  Neurosense Therapeutics

 Performance 
       Timeline  
Century Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Century Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Century Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Neurosense Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Neurosense Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Neurosense Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Century Therapeutics and Neurosense Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Century Therapeutics and Neurosense Therapeutics

The main advantage of trading using opposite Century Therapeutics and Neurosense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, Neurosense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurosense Therapeutics will offset losses from the drop in Neurosense Therapeutics' long position.
The idea behind Century Therapeutics and Neurosense Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments